DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Davies M, Osborne V, Lane S. et al.
Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.
Drug Saf 2020;
43: 645-656
We do not assume any responsibility for the contents of the web pages of other providers.